Quick Dispatch:
Your tirzepatide and kidney disease A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes (TREASURE-CKD) orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your tirzepatide and kidney disease A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes (TREASURE-CKD) ships.
Need Help?
Questions about tirzepatide and kidney disease A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes (TREASURE-CKD), sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for tirzepatide and kidney disease A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes (TREASURE-CKD) in your area.
Tirzepatide linked to lower risk for death, adverse CV and kidney outcomes vs. GLP-1s
24.24
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
23.87
This isn't just a weight loss shot… 👀 Tirzepatide is changing the way we think about metabolism, heart health, and even kidney protection. Swipe to see what's really happening inside your body
27.43
TREASURE
22.15
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial
22.76
Tirzepatide Associated with Lower Risk of Heart and Kidney Damage Compared to Dulaglutide in Patients with Type 2 Diabetes and Cardiovascular Disease
25.61
Diabetic cardiorenal injury and preventive treatments. Type 2 diabetes
27.26
